Your browser doesn't support javascript.
loading
Mid-term results of patterned laser trabeculoplasty for uncontrolled ocular hypertension and primary open angle glaucoma.
Espinoza, Gustavo; Castellanos-Castellanos, Yuly Andrea; Pedraza-Concha, Angelica; Rodríguez-Una, Ignacio; Acuña, Maria Fernanda; Parra, Juan Camilo.
Afiliação
  • Espinoza G; Centro Oftalmológico Virgilio Galvis, Bucaramanga, Santander 681004, Colombia.
  • Castellanos-Castellanos YA; Fundación Oftalmológica de Santander, Bucaramanga, Santander 681004, Colombia.
  • Pedraza-Concha A; Fundación Oftalmológica de Santander, Bucaramanga, Santander 681004, Colombia.
  • Rodríguez-Una I; Fundación Oftalmológica de Santander, Bucaramanga, Santander 681004, Colombia.
  • Acuña MF; Universidad Industrial de Santander, Bucaramanga, Santander 680002, Colombia.
  • Parra JC; Instituto Oftalmológico Fernández-Vega, Universidad de Oviedo, Oviedo 33012, Spain.
Int J Ophthalmol ; 14(8): 1199-1204, 2021.
Article em En | MEDLINE | ID: mdl-34414084
ABSTRACT

AIM:

To describe the safety and efficacy of patterned laser trabeculoplasty (PLT) as an adjunctive treatment in primary open angle glaucoma (POAG) and ocular hypertension (OHT) after 18-month follow-up in Hispanic population.

METHODS:

A single-center, retrospective study was conducted. All patients with OHT or POAG undergoing PLT from June 2016 to August 2016 were included in the study. Investigated parameters were intraocular pressure (IOP), the number of IOP-lowering medications, best corrected visual acuity (BCVA), laser parameters and postoperative adverse events. Primary efficacy outcome measures were the proportion of eyes achieving an IOP reduction ≥20% at 18mo versus baseline medicated IOP or a reduction in the number of medications while maintaining IOP values.

RESULTS:

From 40 PLT-treated eyes (mean baseline IOP 20.3±1.7 mm Hg), 24 patients were analyzed (age 63.4±7.3y). The mean IOP reductions from baseline across visits (months 1, 3, 6, 9, 12, and 18) ranged from 14.1% to 20.8%. Success rate after 18-month follow-up was 61.7% with a mean IOP of 16±3.2 mm Hg (P<0.001). The number of glaucoma IOP-lowering medications per eye (preoperative 2.1±1.1 and postoperative 2.3±1.1, P=0.86) and the mean BCVA (preoperative 0.10±0.22 and postoperative 0.11±0.22 logMAR, P=0.42) remained stable. Adverse events comprised transitory IOP spikes in 4 eyes (10%) and peripheral anterior synechiae in 7 eyes (17.5%).

CONCLUSION:

Mid-term results of PLT show that this procedure may be an efficacious and safe technique to approach medically uncontrolled OHT or POAG patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article